Detalhe da pesquisa
1.
Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial.
PLoS One
; 17(5): e0267592, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511761